1. Short title This Act may be cited as the National Milestones to Measure Progress in Ending the Opioid Epidemic Act of 2018 . 2. National milestones to measure success in curtailing the Opioid Epidemic (a) In general Not later than 180 days after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this Act as the Secretary ), in consultation with the Administrator of the Drug Enforcement Administration and the Director of the Office of National Drug Control Policy, shall develop national indicators to measure success in curtailing the opioid epidemic, with the goal of significantly reversing the toll of opioid misuse and opioid-related morbidity and mortality in the United States within 5 years of such date of enactment (referred to in this section as the national milestones ). (b) National milestones To end the opioid epidemic The national milestones under subsection (a) shall include the following: (1) The establishment of not fewer than 10 indicators or metrics to accurately and expediently measure progress in meeting the goal described in subsection (a)(1), which shall include— (A) a reduction in fatal and non-fatal opioid overdoses; (B) a reduction in emergency room visits related to opioid misuse and abuse; (C) an increase in public and provider education, including a focus on reducing stigma associated with opioid use disorder; (D) an increase in the number of individuals in sustained recovery from opioid use disorder; (E) a reduction in the number of co-infections associated with injection drug use, such as HIV, viral hepatitis, and endocarditis, and an expanded capacity to reduce initial infections and enhance access to treatment; (F) an increase in the number of providers prescribing medically assisted treatment for opioid use disorder in different settings, including primary care, community health centers, jails, and prisons; (G) an increase in the number of harm reduction organizations, including syringe services programs and naloxone distribution programs